Article du mois d’Octobre
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz‑Ares, L. Horn, D.R. Spigel, M. Steins, N.E. Ready, L.Q. Chow,
E.E. Vokes, E. Felip, E. Holgado, F. Barlesi, M. Kohlhäufl, O. Arrieta, M.A. Burgio,
J. Fayette, H. Lena, E. Poddubskaya, D.E. Gerber, S.N. Gettinger, C.M. Rudin,
N. Rizvi, L. Crinò, G.R. Blumenschein, Jr., S.J. Antonia, C. Dorange,
C.T. Harbison, F. Graf
Finckenstein, and J.R. Brahmer
New England Journal of Medicine (Impact Factor: 55.87). 09/2015